BCAL Diagnostics Ltd

NEW
ASX:BDX (Australia)   Ordinary Shares
A$ 0.067 -0.0020 (-2.9%) Sep 7
At Loss
Market Cap:
A$ 24.70M ($ 17.83M)
Enterprise V:
A$ 30.03M ($ 21.68M)
Volume:
10.15K
Avg Vol (2M):
105.64K
Trade In:
Volume:
10.15K
At Loss
Avg Vol (2M):
105.64K

BCAL Diagnostics Ltd (ASX:BDX) Dividend

BCAL Diagnostics Ltd (ASX:BDX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -20.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:BDX Dividend

Does BCAL Diagnostics Ltd (ASX:BDX) pay a dividend?

BCAL Diagnostics Ltd (ASX:BDX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BCAL Diagnostics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BCAL Diagnostics Ltd has returned capital to shareholders via buybacks at a rate of -20.2% over the past 3 years.

What are dividend-paying alternatives to BCAL Diagnostics Ltd?

For dividend-paying alternatives in BCAL Diagnostics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.